INTERPACE BIOSCIENCES, INC. (IDXG) Operating margin 2016–2025
INTERPACE BIOSCIENCES, INC. (IDXG) operating margin by fiscal year — reported operating income divided by reported revenue.
10.5%FY2025 · since FY2016: -49.2% → 10.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 10.5% | -6.7 pp |
| FY2024 | 17.3% | +7.4 pp |
| FY2023 | 9.9% | +21.2 pp |
| FY2022 | -11.4% | +7.8 pp |
| FY2021 | -19.1% | +61.3 pp |
| FY2020 | -80.5% | +28.7 pp |
| FY2019 | -109.1% | -51.5 pp |
| FY2018 | -57.7% | -18.1 pp |
| FY2017 | -39.6% | +9.6 pp |
| FY2016 | -49.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IDXG financial trends
IDXG RevenueIDXG Net incomeIDXG Net marginIDXG Gross profitIDXG Gross marginIDXG Operating incomeIDXG Operating cash flowIDXG Free cash flowIDXG Capital expendituresIDXG Return on equityIDXG Stock buybacksIDXG Dividends paidIDXG Total assetsIDXG Total liabilitiesIDXG Shareholders’ equityIDXG overview →